Hepatitis E virus infection in Ghanaian blood donors - the importance of immunoassay selection and confirmation

Vox Sanguinis

Volumn 104, Issue 1, 2013, Pages 30-36

  Meldal, B H M ^a   Sarkodie, F ^b   Owusu Ofori, S ^b   Allain, J P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

Author keywords

Blood donation testing; Molecular testing; NAT testing; Serological testing; Transfusion transmissible infections

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; BLOOD DONOR; BLOOD SAFETY; CONTROLLED STUDY; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; GHANA; HEPATITIS E; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS TRANSMISSION; WESTERN BLOTTING;

BLOOD BANKS; BLOOD DONORS; BLOOD SAFETY; DONOR SELECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GHANA; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; RNA; RNA, VIRAL;

EID: 84871315357     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2012.01637.x     Document Type: Article

References (48)

1. Ray R, Aggarwal R, Salunke PN, et al.: Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India. Lancet 1991; 338:783-784.
2. Goumba CM, Yandoko-Nakoune ER, Komas NP: A fatal case of acute hepatitis E among pregnant women, Central African Republic. BMC Res Notes 2010; 3:103.
3. Khan A, Tanaka Y, Kurbanov F, et al.: Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan. J Med Virol 2011; 83:622-629.
4. Ijaz S, Arnold E, Banks M, et al.: Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics. J Infect Dis 2005; 192:1166-1172.
5. Wichmann O, Schimanski S, Koch J, et al.: Phylogenetic and case-control study on hepatitis E virus infection in. J Infect Dis 2008; 198:1732-1741.
6. Matsubayashi K, Kang JH, Sakata H, et al.: A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008; 48:1368-1375.
7. Gotanda Y, Iwata A, Ohnuma H, et al.: Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan. J Med Virol 2007; 79:734-742.
8. Christensen PB, Engle RE, Hjort C, et al.: Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008; 47:1026-1031.
9. Takeda H, Matsubayashi K, Sakata H, et al.: A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang 2010; 99:307-313.
10. Purcell RH, Emerson SU: Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48:494-503.
11. Matsubayashi K, Nagaoka Y, Sakata H, et al.: Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004; 44:934-940.
12. Mitsui T, Tsukamoto Y, Yamazaki C, et al.: Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004; 74:563-572.
13. Boxall E, Herborn A, Kochethu G, et al.: Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med 2006; 16:79-83.
14. Colson P, Coze C, Gallian P, et al.: Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007; 13:648-649.
15. Tamura A, Shimizu YK, Tanaka T, et al.: Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007; 37:113-120.
16. Gérolami R, Moal V, Picard C, et al.: Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009; 50:622-624.
17. Ollier L, Tieulie N, Sanderson F, et al.: Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009; 150:430-431.
18. Fukuda S, Sunaga J, Saito N, et al.: Prevalence of antibodies to hepatitis E virus among Japanese blood donors: identification of three blood donors infected with a genotype 3 hepatitis E virus. J Med Virol 2004; 73:554-561.
19. Meng XJ, Wiseman B, Elvinger F, et al.: Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 2002; 40:117-122.
20. Mansuy JM, Legrand-Abravanel F, Calot JP, et al.: High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008; 80:289-293.
21. Beale MA, Tettmar K, Szypulska R, et al.: Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors?Vox Sang 2011; 100:340-342.
22. Sakata H, Matsubayashi K, Takeda H, et al.: A nationwide survey for hepatitis E virus prevalence in Japanese blood donors with elevated alanine aminotransferase. Transfusion 2008; 48:2568-2576.
23. Martinson FE, Marfo VY, Degraaf J: Hepatitis E virus seroprevalence in children living in rural Ghana. West Afr J Med 1999; 18:76-79.
24. Adjei AA, Tettey Y, Aviyase JT, et al.: Hepatitis E virus infection is highly prevalent among pregnant women in Accra, Ghana. Virol J 2009; 6:108-112.
25. Gibson KE, Opryszko MC, Schissler JT, et al.: Evaluation of human enteric viruses in surface water and drinking water resources in southern Ghana. Am J Trop Med Hyg 2011; 84:20-29.
26. Stiehm ER, Ochs HD, Winkelstein JA: Immunologic Disorders in Infants and Children. 5th edn, Philadelphia, London, Saunders, 2004: 1512.
27. Jothikumar N, Cromeans TL, Robertson BH, et al.: A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006; 131:65-71.
28. Meng XJ, Purcell RH, Halbur PG, et al.: A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 1997; 94:9860-9865.
29. Huang FF, Haqshenas G, Guenette DK, et al.: Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J Clin Microbiol 2002; 40:1326-1332.
30. Ferguson M, Walker D, Mast E, et al.: Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biologicals 2002; 30:43-48.
31. Mast EE, Alter MJ, Holland PV, et al.: Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998; 27:857-861.
32. Fix AD, Abdel-Hamid M, Purcell RH, et al.: Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg 2000; 62:519-523.
33. Lin CC, Wu JC, Chang TT, et al.: Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol 2000; 38:3915-3918.
34. Myint KS, Endy TP, Gibbons RV, et al.: Evaluation of diagnostic assays for hepatitis E virus in outbreak settings. J Clin Microbiol 2006; 44:1581-1583.
35. Bendall R, Ellis V, Ijaz S, et al.: Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 2008; 80:95-101.
36. Bendall R, Ellis V, Ijaz S, et al.: A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82:799-805.
37. Dalton HR, Bendall RP, Keane FE, et al.: Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361:1025-1027.
38. Ma H, Song X, Harrison TJ, et al.: Hepatitis E virus ORF3 antigens derived from genotype 1 and 4 viruses are detected with varying efficiencies by an anti-hev enzyme immunoassay. J Med Virol 2011; 83:827-832.
39. Drobeniuc J, Meng J, Reuter G, et al.: Serologic Assays Specific to Immunoglobulin M Antibodies against Hepatitis E Virus: Pangenotypic Evaluation of Performances. Clin Infect Dis 2010; 51:e24-e27.
40. Pan JS, Zhang K, Zhou J, et al.: Application of truncated immunodominant polypeptide from hepatitis E virus (HEV) ORF2 in an assay to exclude non-specific binding in detecting anti-HEV IgM. J Clin Microbiol 2010; 48:779-784.
41. Pawlotsky JM, Belec L, Gresenguet G, et al.: High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol 1995; 46:269-272.
42. Tucker TJ, Kirsch RE, Louw SJ, et al.: Hepatitis E in South Africa: evidence for sporadic spread and increased seroprevalence in rural areas. J Med Virol 1996; 50:117-119.
43. Menendez C, Sanchez-Tapias JM, Kahigwa E, et al.: Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999; 58:215-220.
44. Stoszek SK, Abdel-Hamid M, Saleh DA, et al.: High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006; 100:95-101.
45. Caron M, Kazanji M: Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas. Virol J 2008; 5:158-161.
46. Hannachi N, Hidar S, Harrabi I, et al.: Séroprévalence et facteurs de risque de l'hépatite virale E chez la femme enceinte dans le centre tunisien. Pathol Biol (Paris) 2009; 59:e115-e118.
47. Fogeda M, de Ory F, Avellon A, et al.: Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J Clin Virol 2009; 45:259-261.
48. Compston LI, Li C, Sarkodie F, et al.: Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol 2009; 81:1860-1868.